Plandaí Biotechnology's Upcoming Clinical Trial Could Strengthen Case for Phytofare in Treatment of Diabetes
May 18, 2017 09:00 ET | Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - May 18, 2017) - Plandaí Biotechnology (OTCQB: PLPL) announced that it will conduct a human clinical trial to study the effectiveness of using its highly bioavailable...
Plandaí Biotechnology Changing the Future of Green Tea with Technology Used in Origine 8 Capsules
May 10, 2017 09:00 ET | Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - May 10, 2017) - Plandaí Biotechnology's (OTCQB: PLPL) Origine 8™ capsules could be the future of green tea. Drinking a cup of green tea tastes great, but unless the eight...
Plandai Biotechnology Expanding Footprint of Phytofare into U.S. with Continued Sales
May 04, 2017 09:00 ET | Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - May 04, 2017) - Plandaí Biotechnology (OTCQB: PLPL) announced last week that its highly bioavailable Phytofare® Catechin Complex would be the active ingredient in Capital...
Plandai Biotechnology Gains Credibility with NutriBullet Deal
April 26, 2017 09:00 ET | Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - April 26, 2017) - Plandaí Biotechnology (OTCQB: PLPL) expects Capital Brands, LLC, the developer, marketer, and distributor of both the wildly popular NutriBullet and...
Plandai Biotechnology Sets Aggressive Agenda for 2017
April 19, 2017 09:00 ET | Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - April 19, 2017) - Plandaí Biotechnology (OTCQB: PLPL) recently presented investors with its outlook for 2017 and a number of milestones that the company plans to...
Plandai Biotechnology, Inc.'s Tomato Based Product Offers Benefits for Certain Cancers
May 28, 2013 08:30 ET | Plandai Biotechnology, Inc.
NEW YORK, NY--(Marketwired - May 28, 2013) - Plandaí Biotechnology, Inc.'s (OTCQB: PLPL) Phytofare™ brand will feature three botanical extracts with a much higher bioavailability than...